Compound ID | 706
BL2060
Class: Antimicrobial peptide (peptidomimetic oligomer)
| Spectrum of activity: | Gram-positive |
| Details of activity: | When inhaled by P. aeruginosa infected mice, there was a 2 log reduction in bacterial population compared to controls. |
| Description: | Mor A, Shahar I, Klapper L, Ron H, Halbfinger E, Zehavy Y, et al. BL-2060 a broad spectrum antimicrobial peptidomimetic for the treatment of severe lung infections. 48-ICAAC-46-IDSA-2008 2008;327 |
| Institute where first reported: | Bioline Innovations, Israel |
| Year first mentioned: | 2008 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167646/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.